NCT07511270 Prediction of Cognitive Test Performance Using AI-Based Analysis of Narrative Speech
| NCT ID | NCT07511270 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Cognitive Function Assessment |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2025-12-01 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate a new artificial intelligence (AI)-based method for measuring cognitive function using speech recordings. Participants will complete a short storytelling task in which they describe a story based on an image while their voice is recorded using a computer or mobile device. The speech recordings will be analyzed using AI technology to identify patterns in speech that may be related to cognitive function. The system will then estimate scores that correspond to commonly used cognitive tests. To evaluate the accuracy of this method, the AI-generated scores will be compared with results from standard cognitive assessments administered by trained researchers. These assessments may include tests commonly used to measure memory, attention, and other cognitive abilities. The goal of this study is to determine whether speech analysis using AI can provide a convenient and efficient approach for cognitive assessment. If successful, this technology may help support early detection of cognitive decline and provide a practical tool for large-scale or remote cognitive screening.
Eligibility Criteria
Inclusion Criteria: 1. Age 50 years or older 2. Able to communicate verbally and understand study instructions 3. Able to hear and speak clearly 4. Willing and able to provide written informed consent Exclusion Criteria: 1. Severe speech or hearing impairment 2. History of major psychiatric disorders 3. History of stroke, traumatic brain injury, Parkinson's disease, epilepsy, or other neurodegenerative diseases 4. Current use of medications that may affect cognitive performance 5. Unable to complete the study procedures due to severe attention deficits or agitation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07511270 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Cognitive Function Assessment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07511270 currently recruiting?
Yes, NCT07511270 is actively recruiting participants. Contact the research team at cywu@mail.cgu.edu.tw for enrollment information.
Where is the NCT07511270 trial being conducted?
This trial is being conducted at Taoyuan, Taiwan.
Who is sponsoring the NCT07511270 clinical trial?
NCT07511270 is sponsored by Chang Gung Memorial Hospital. The trial plans to enroll 150 participants.